14.20
전일 마감가:
$13.87
열려 있는:
$14.02
하루 거래량:
66,380
Relative Volume:
0.72
시가총액:
$182.50M
수익:
$16.96M
순이익/손실:
$-23.88M
주가수익비율:
-6.7716
EPS:
-2.097
순현금흐름:
$-20.66M
1주 성능:
+2.45%
1개월 성능:
-13.47%
6개월 성능:
-23.66%
1년 성능:
-28.21%
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
MDWD
Mediwound Ltd
|
14.20 | 179.29M | 16.96M | -23.88M | -20.66M | -2.097 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2025-05-02 | 개시 | Alliance Global Partners | Buy |
| 2025-02-28 | 개시 | Craig Hallum | Buy |
| 2024-07-16 | 재확인 | Maxim Group | Buy |
| 2022-12-22 | 개시 | Maxim Group | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-09-23 | 개시 | BTIG Research | Buy |
| 2016-11-28 | 개시 | Aegis Capital | Buy |
| 2016-08-17 | 개시 | Wells Fargo | Outperform |
| 2014-04-16 | 개시 | Oppenheimer | Outperform |
모두보기
Mediwound Ltd 주식(MDWD)의 최신 뉴스
MDWD Q1 2026 Earnings: Strong Beat on EPS Despite Narrower LossEBITDA Margin Trends - newsline.com
MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Surprises to the UpsideFinancial Data - newsline.com
MediWound (MDWD) Sheds 1.87% as Stock Holds Above Key Support LevelAccumulation Line - newsline.com
MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47Wave Equality - newsline.com
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Craig Hallum Forecasts MediWound's Q3 Earnings (NASDAQ:MDWD) - MarketBeat
Maxim Group Issues Negative Estimate for MediWound Earnings - MarketBeat
Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD) - GuruFocus
Director at MediWound (MDWD) buys 6,000 ordinary shares in market - Stock Titan
MediWound Ltd. Stock Plummets to New 52-Week Low of $13.58 - Markets Mojo
Insider Buying: David Fox Acquires Shares of MediWound Ltd (MDWD) - GuruFocus
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) director buys 3,537 ordinary shares on open market - Stock Titan
MediWound Q1 earnings call highlights - MSN
Director Rubinstein buys MediWound (MDWD) shares and holds multiple options - Stock Titan
MediWound Shares Slide This Week; BARDA Moves in Focus - Bez Kabli
MediWound Ltd. Hits New 52-Week Low at USD 14.14 - MarketsMojo
MediWound (MDWD) Slips 1.58% as Stock Holds Near Critical Support at $13.61Price Momentum Stocks - The Legal Advocate
MediWound (MDWD) Insider Trading Activity 2026 - MarketBeat
5 Stocks Better Than MediWound as Q1 Revenue Declines - HarianBasis.co
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
MDWD Maintains Outperform by Oppenheimer -- Price Target Lowered to $32 - GuruFocus
MDWD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $36 - GuruFocus
Oppenheimer Adjusts MediWound Price Target to $32 From $33, Maintains Outperform Rating - Moomoo
Oppenheimer Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $32 - Moomoo
Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely? - Yahoo Finance
MediWound Ltd. (NASDAQ:MDWD) Q1 2026 Earnings Call Transcript - Insider Monkey
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $36 - Moomoo
MediWound: Q1 Earnings Snapshot - AOL.com
MediWound Q1 2026 Earnings Call Transcript - MarketBeat
MediWound (MDWD) Q1 Loss Of US$0.23 Per Share Reinforces Bearish Profitability Narratives - simplywall.st
Q3 2025 Mediwound Ltd Earnings Call Transcript - GuruFocus
Q1 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus
MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue Challenges - GuruFocus
Oppenheimer lowers MediWound stock price target to $32 on revenue miss - Investing.com UK
Oppenheimer lowers MediWound stock price target to $32 on revenue miss By Investing.com - Investing.com Australia
MediWound Q1 2026 earnings preview - MSN
MediWound (MDWD) reports Q1 2026 results, reaffirms guidance - grafa.com
MediWound Q1 Earnings Call Highlights - sharewise.com
MediWound (MDWD) Reports Q1 Revenue Below Expectations - GuruFocus
MediWound Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Mediwound Ltd reports results for the quarter ended March 31Earnings Summary - TradingView
MediWound Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MEDIWOUND ($MDWD) Releases Q1 2026 Earnings - Quiver Quantitative
MediWound Q1 2026 Results Highlight EscharEx Trial Progress and BARDA Boost for NexoBrid - TipRanks
MDWD: Q1 revenue fell but margin improved; EscharEx and NexoBrid progress support 2026 outlook - TradingView
MediWound (NASDAQ: MDWD) Q1 2026 revenue drops as 2026 guidance held - Stock Titan
Mediwound Ltd (MDWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mediwound Ltd 주식 (MDWD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Fox David Morton | Director |
Jun 01 '26 |
Buy |
14.11 |
3,537 |
49,901 |
22,283 |
| Rubinstein Samuel | Director |
May 29 '26 |
Buy |
14.33 |
150 |
2,150 |
2,993 |
자본화:
|
볼륨(24시간):